Compare NEO & VRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEO | VRTS |
|---|---|---|
| Founded | 2001 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 992.3M |
| IPO Year | 2008 | 1995 |
| Metric | NEO | VRTS |
|---|---|---|
| Price | $8.11 | $128.84 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | $11.14 | ★ $171.60 |
| AVG Volume (30 Days) | ★ 1.9M | 63.9K |
| Earning Date | 05-18-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 7.26% |
| EPS Growth | N/A | ★ 18.24 |
| EPS | N/A | ★ 19.97 |
| Revenue | N/A | N/A |
| Revenue This Year | $10.63 | N/A |
| Revenue Next Year | $9.73 | $3.84 |
| P/E Ratio | ★ N/A | $6.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.72 | $127.83 |
| 52 Week High | $13.74 | $214.88 |
| Indicator | NEO | VRTS |
|---|---|---|
| Relative Strength Index (RSI) | 20.55 | 31.26 |
| Support Level | $7.07 | N/A |
| Resistance Level | $8.89 | $169.44 |
| Average True Range (ATR) | 0.47 | 5.37 |
| MACD | -0.09 | -0.30 |
| Stochastic Oscillator | 11.30 | 6.90 |
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.